The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults With Type 2 Diabetes Mellitus.

The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults With Type 2 Diabetes Mellitus.
复制标题

DOI:
10.1016/j.psym.2016.08.003
复制
发表时间:
2017-01
期刊:
影响因子:
3.4
通讯作者:
Lyketsos C
Lyketsos C
中科院分区:
医学4区
文献类型:
--
作者:
Golden SH;Shah N;Naqibuddin M;Payne JL;Hill-Briggs F;Wand GS;Wang NY;Langan S;Lyketsos C

文献摘要

参考文献

被引文献

相似文献

评估以临床为基础的成人2型糖尿病人群中轻度抑郁障碍(Mind)的粗略患病率。我们使用患者健康问卷-2对702名成年2型糖尿病患者的抑郁症状进行了筛查,并对52名筛查阳性和51名筛查阴性的患者进行了结构化的精神病学诊断访谈。抑郁障碍的诊断使用精神疾病诊断和统计手册IV(DSM-IV)文本修订的标准,并被归类为精神、严重抑郁障碍(MDD)或无抑郁障碍。我们估计了精神疾病和MDD的患病率,并得出了95%的CI。现在、过去和现在或过去心理的粗略患病率分别为4.3%(95%CI:0.9-9.2%)、9.6%(95%CI:3.9-15.9%)和13.9%(95%CI:7.7-21.2%)。现在、过去和现在或过去MDD的粗患率略高,分别为5.0%(95%可信区间:1.9-9.4%)、12.0%(95%可信区间:6.1-19.5%)和17.0%(95%可信区间:10.1-24.8%)。在有心理障碍(42.2%)和精神障碍(8.1%)的个体中,焦虑障碍并存的患病率很高。与那些没有抑郁障碍的人相比,有精神障碍或MDD的人的血红蛋白A1c水平没有显著差异。精神疾病在2型糖尿病患者中的流行程度与MDD相当;这两种疾病都与伴随的焦虑障碍有关。Mind不包括在DSM-5中;然而,我们的数据支持继续检查患有慢性疾病的患者的Mind。
To estimate the crude prevalence of minor depressive disorder (MinD) in a clinic-based population of adults with type 2 diabetes. We screened a clinical sample of 702 adults with type 2 diabetes for depressive symptoms using the Patient Health Questionnaire-2 and performed a structured diagnostic psychiatric interview on 52 screen-positive and a convenience sample of 51 screen-negative individuals. Depressive disorder diagnoses were made using Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) Text Revised criteria and categorized as MinD, major depressive disorder (MDD), or no depressive disorder. We estimated prevalence of MinD and MDD and derived 95% CIs. The crude prevalence of current, past, and current or past MinD was 4.3% (95% CI: 0.9–9.2%), 9.6% (95% CI: 3.9–15.9%), and 13.9% (95% CI: 7.7–21.2%), respectively. The crude prevalence of current, past, and current or past MDD was slightly higher—5.0% (95% CI: 1.9–9.4%), 12.0% (95% CI: 6.1–19.5%), and 17.0% (95% CI: 10.1–24.8%), respectively. There was a high prevalence of coexisting anxiety disorders in individuals with MinD (42.2%) and MDD (8.1%). Hemoglobin A1c levels were not significantly different in individuals with MinD or MDD compared to those without a depressive disorder. MinD is comparably prevalent to MDD in patients with type 2 diabetes; both disorders are associated with concomitant anxiety disorders. MinD is not included in the DSM-5; however, our data support continuing to examine patients with chronic medical conditions for MinD.
DOI: 10.1186/1758-5996-2-72
发表时间: 2010-12-20
影响因子: 4.8
作者:
Khuwaja AK;Lalani S;Dhanani R;Azam IS;Rafique G;White F
通讯作者: White F
DOI: 10.1016/j.maturitas.2016.01.003
发表时间: 2016-04-01
期刊: MATURITAS
影响因子: 4.9
作者:
Almeida, Osvaldo P.;McCaul, Kieran;Flicker, Leon
通讯作者: Flicker, Leon
DOI: 10.1371/journal.pmed.0050045
发表时间: 2008-02
期刊: PLOS MEDICINE
影响因子: 15.8
作者:
Kirsch, Irving;Deacon, Brett J.;Huedo-Medina, Tania B.;Scoboria, Alan;Moore, Thomas J.;Johnson, Blair T.
通讯作者: Johnson, Blair T.
DOI: 10.1016/j.psym.2013.02.015
发表时间: 2013-09-01
期刊: PSYCHOSOMATICS
影响因子: 3.4
作者:
Coleman, Shane M.;Katon, Wayne;Von Korff, Michael
通讯作者: Von Korff, Michael
DOI: 10.1007/s11892-010-0148-9
发表时间: 2010-12-01
影响因子: 4.2
作者:
Champaneri, Shivam;Wand, Gary S.;Golden, Sherita Hill
通讯作者: Golden, Sherita Hill